PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT)

Authors
MURAD AM GUIMARAES RC ARAGAO BC SCALABRININETO AO
Citation
Am. Murad et al., PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT), Annals of oncology, 9, 1998, pp. 325-325
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
325 - 325
Database
ISI
SICI code
0923-7534(1998)9:<325:PTOTUO>2.0.ZU;2-3